Screener
Monte Rosa Therapeutics, Inc. GLUE Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
FAQ
- What is Monte Rosa Therapeutics, Inc.'s operating lease liabilities (current)?
- Monte Rosa Therapeutics, Inc. (GLUE) reported operating lease liabilities (current) of $4.63M in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s operating lease liabilities (current) increased by 13.1% year-over-year, from $4.09M to $4.63M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Monte Rosa Therapeutics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude